Race Oncology
RAC.AX
#8800
Rank
โ‚น9.92 B
Marketcap
โ‚น57.13
Share price
4.50%
Change (1 day)
-19.41%
Change (1 year)

P/E ratio for Race Oncology (RAC.AX)

P/E ratio at the end of 2023: -19.4

According to Race Oncology's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -16.4087. At the end of 2023 the company had a P/E ratio of -19.4.

P/E ratio history for Race Oncology from 2016 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2023-19.4-18.24%
2022-23.8-63.1%
2021-64.5322%
2020-15.31275.63%
2019-1.11-42.55%
2018-1.93-18.57%
2017-2.37-70.75%
2016-8.12

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.